Kore Private Wealth’s Protalix BioTherapeutics PLX Stock Holding History

Kore Private Wealth’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500	Closed	-$2K	–	639
2019 Q1	$2K	Hold	500	–	–	﹤0.01%	860
2018 Q4	$2K	Buy	+500	New	+$2.38K	﹤0.01%	811

Other funds holding PLX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Kore Private Wealth's PLX Position: Q2 2019 in Review

Kore Private Wealth sold out of Protalix BioTherapeutics (PLX) in Q2 2019, closing a stake of 500 shares — an estimated $2K sold.

Kore Private Wealth first reported a position in PLX in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 31 funds tracked by Wall St. Rank hold PLX as of Q2 2019.

Kore Private Wealth reported no remaining Protalix BioTherapeutics position as of Q2 2019 after selling out during the quarter.
Kore Private Wealth sold 500 Protalix BioTherapeutics shares in Q2 2019, an estimated $2K.
Kore Private Wealth first reported a position in Protalix BioTherapeutics in Q4 2018 and held it in 2 quarters.
Kore Private Wealth's Protalix BioTherapeutics position peaked at $2K in Q1 2019.
31 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q2 2019.

Based on Kore Private Wealth's 13F filing for Q2 2019, filed 14 Aug 2019.